Cocrystal Pharma (COCP) Other Working Capital Changes (2010 - 2026)
Cocrystal Pharma (COCP) reported Other Working Capital Changes of $90000.0 for Q1 2026, up 300.0% on a YoY basis from $22500.0 in Q1 2025, and up 145.45% sequentially from -$198000.0 in Q4 2025.
Cocrystal Pharma (COCP) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 15 years of Other Working Capital Changes data on file, last reported at $90000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 300.0% year-over-year to $90000.0; the trailing twelve-month figure through Mar 2026 stood at $33000.0 (up 102.78% YoY), and the FY2025 full-year result was -$102000.0, up 92.41% from the prior year.
- Other Working Capital Changes slipped to -$81000.0 in Q1 2026, from -$75000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of -$31000.0 in Q1 2024 to a low of -$81000.0 in Q1 2026.
- A 4-year average of -$62333.3 and a median of -$69000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes jumped 341.28% in 2022 and tumbled 957.89% in 2024, its largest moves.
- Tracing COCP's Other Working Capital Changes over 4 years: stood at -$59000.0 in 2023, then declined by 16.95% to -$69000.0 in 2024, then slipped by 8.7% to -$75000.0 in 2025, then fell by 8.0% to -$81000.0 in 2026.
- Business Quant data shows COCP's Other Working Capital Changes at -$81000.0 in Q1 2026, -$75000.0 in Q3 2025, and -$75000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90,000.00 |
| Mar 31, 2026 | 90,000.00 |
| Mar 31, 2026 | 90,000.00 |
| Dec 31, 2025 | -198,000.00 |
| Dec 31, 2025 | -198,000.00 |
| Dec 31, 2025 | -198,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Sep 30, 2024 | 127,000.00 |
| Sep 30, 2024 | 127,000.00 |